Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Pancreatic Cancer Research Group, The Garvan Institute

Sydney, New South Wales AUSTRALIA

Magenta Marker Pancreatic Cancer Research Group, The Garvan Institute
384 Victoria Street
Darlinghurst NSW 2010
+612 9295 8100

www.garvan.org.au‎

The Garvan Institute of Medical Research is a world leader in biomedical research, pioneering study into some of the most widespread diseases affecting our community today. Research at Garvan is focused on understanding the role of genes in health and disease as the basis for developing future cures. For over 45 years, significant breakthroughs have been achieved by Garvan scientists in the understanding and treatment of diseases.

The Pancreatic Cancer Research Team is striving to improve the diagnosis, prognosis and treatments for patients with pancreatic cancer.

-33.8791234 151.2212473
384 Victoria Street
Darlinghurst NSW 2010
+612 9295 8100

www.garvan.org.au‎

The Garvan Institute of Medical Research is a world leader in biomedical research, pioneering study into some of the most widespread diseases affecting our community today. Research at Garvan is focused on understanding the role of genes in health and disease as the basis for developing future cures. For over 45 years, significant breakthroughs have been achieved by Garvan scientists in the understanding and treatment of diseases.

The Pancreatic Cancer Research Team is striving to improve the diagnosis, prognosis and treatments for patients with pancreatic cancer.